Historical review from 2026-11-15. Current price and availability are unconfirmed; check the original marketplace.
Nose Job – Plastic Surgery AI is a verified, 11-month-old AI face-preview app generating $1,893/mo in profit on $3,156/mo revenue at a solid 60% margin. The $45,000 asking price represents just under a 2.0x annual profit multiple, which is well below typical SaaS or AI app market rates and provides meaningful downside cushion. The rhinoplasty/aesthetic preview use case targets a high-intent audience with strong emotional and financial stakes, supporting willingness to pay. The main open questions center on customer concentration, acquisition channel durability, and whether revenue has been consistent across the app's 11-month history.
The underlying technology — AI face transformation using an existing image-generation or face-swap API layered over a mobile frontend — is reproducible at MVP scope for roughly $4K–$10K using AI-assisted coding tools and third-party vision APIs. Build time is secondary. The buy case is driven primarily by 11 months of verified revenue, a paying user base, and an established App Store presence that generates organic credibility and discovery. At under 2x annual profit, the acquisition price offers a margin of safety that makes purchasing the proven traction meaningfully more capital-efficient than rebuilding and re-acquiring customers from scratch. Missing churn and customer-count data are the primary confidence gaps a buyer should address in diligence.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
AI face preview app for people considering facial aesthetic procedures. Users upload a selfie and see a realistic preview of rhinoplasty, eyelid, chin, lip, jawline and other facial changes on their o
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.